Physician profile
Volodymyr Labinskyy
NPI 1538317334
$21,912.38
in general payments reported to CMS, 2019-2025
18 companies · $1,184 in 2025
The $1,184 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $47.04 · 2021: $534 · 2022: $8,890 · 2023: $10K · 2024: $869 · 2025: $1,184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $9,033 · Food and Beverage: $3,269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $9,033.34 |
| Food and Beverage | $3,269.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $17,537.79 | 2021-2023 | Auryon Laser System 100-120 Vac |
| Tactile Systems Technology INC | $1,486.48 | 2021-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Medtronic, INC. | $1,144.22 | 2021-2025 | Hawkone, Endurant Iis, Abre |
| Endologix LLC | $585.55 | 2021-2025 | Alto Abdominal Stent Graft System, Afx2 Bifurcated Endograft System |
| Janssen Pharmaceuticals, INC | $224.86 | 2021-2024 | Xarelto |
| Bard Peripheral Vascular, INC. | $193.44 | 2019-2024 | Crosser Iq |
| Organogenesis INC. | $154.40 | 2023-2025 | Puraply, Puraply Wound Matrix |
| Penumbra, INC. | $124.43 | 2021-2025 | Penumbra System |
| Integra Lifesciences Corporation | $80.80 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| 180 Medical, INC. | $76.92 | 2024-2025 | Jobst Relief |
| Bolton Medical INC | $65.31 | 2019 | |
| Advanced Oxygen Therapy INC. | $63.33 | 2022-2024 | Topical Oxygen Chamber For Extremities, Topical Oxygen Chamber For Extremities |
| Bioventus LLC | $43.61 | 2023 | Theragenesis Bilayer Wound Matrix |
| Boston Scientific Corporation | $38.16 | 2024 | Varithena Administration Pack |
| Lemaitre Vascular, INC. | $28.46 | 2023 | Hydro Lemaitre Valvulotome |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $25.18 | 2022 | |
| Urgo Medical North America, LLC | $24.81 | 2024 | Urgok2 |
| Smith+Nephew, INC. | $14.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Volodymyr Labinskyy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.